Israeli company Lumen, founded in 2014, has raised $62 million in a Series B funding round led by Pitango Growth. Participating investors include Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital and Disruptive VC. Lumen focuses on a handheld device and a connected app that reveal the state of users’ metabolism through their breath, showing the effects of nutrition and lifestyle on the body. “Understanding the impact of nutrition, exercise, sleep and stress on your metabolism is key to reaching your health goals,” said Daniel Tal, CEO and co-founder of Lumen.
Last year, the company’s app was integrated with Garmin, the Apple Watch and Google Fit. The new funds will go towards an expansion of U.S. and global reach and R&D for a personalized nutrition and lifestyle guidance solution for consumers. Lumen also seeks to support research partnerships with academic institutions.
